Clinical Trial Update: Proton Pump Inhibitor Versus Histamine-2 Receptor Antagonist for the Prevention of Recurrent Peptic Ulcers [NA]

View source ↗

Summary

A completed clinical trial comparing a proton pump inhibitor to a histamine-2 receptor antagonist for preventing recurrent peptic ulcers; results posted in 2019…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peptic Ulcer Disease

Drugs mentioned

• Histamine-2 receptor antagonist
• Proton Pump Inhibitor (proton pump inhibitor)

Snippet

Sponsor: Kaohsiung Veterans General Hospital. | Conditions: Peptic Ulcer | NA | Status: COMPLETED | Results posted: 2019-08-08